BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lankelma JM, van Vught LA, Belzer C, Schultz MJ, van der Poll T, de Vos WM, Wiersinga WJ. Critically ill patients demonstrate large interpersonal variation in intestinal microbiota dysregulation: a pilot study. Intensive Care Med. 2017;43:59-68. [PMID: 27837233 DOI: 10.1007/s00134-016-4613-z] [Cited by in Crossref: 93] [Cited by in F6Publishing: 88] [Article Influence: 15.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang H, Wei C, Min L, Zhu L. Good or bad: gut bacteria in human health and diseases. Biotechnology & Biotechnological Equipment 2018;32:1075-80. [DOI: 10.1080/13102818.2018.1481350] [Cited by in Crossref: 24] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
2 Martin-Loeches I, Dickson R, Torres A, Hanberger H, Lipman J, Antonelli M, de Pascale G, Bozza F, Vincent JL, Murthy S, Bauer M, Marshall J, Cilloniz C, Bos LD. The importance of airway and lung microbiome in the critically ill. Crit Care 2020;24:537. [PMID: 32867808 DOI: 10.1186/s13054-020-03219-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
3 Arulkumaran N, Routledge M, Schlebusch S, Lipman J, Conway Morris A. Antimicrobial-associated harm in critical care: a narrative review. Intensive Care Med 2020;46:225-35. [PMID: 31996961 DOI: 10.1007/s00134-020-05929-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
4 Kang H, Thomas RM. Bacteria and Sepsis: Microbiome to the Rescue? J Clin Med 2021;10:3578. [PMID: 34441874 DOI: 10.3390/jcm10163578] [Reference Citation Analysis]
5 Ding W, Liu J, Zhou X, Miao Q, Zheng H, Zhou B, Dou G, Tong Y, Long Y, Su L. Clinical Multi-Omics Study on the Gut Microbiota in Critically Ill Patients After Cardiovascular Surgery Combined With Cardiopulmonary Bypass With or Without Sepsis (MUL-GM-CSCPB Study): A Prospective Study Protocol. Front Med (Lausanne) 2020;7:269. [PMID: 32733902 DOI: 10.3389/fmed.2020.00269] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
6 Ou WF, Wong LT, Wu CL, Chao WC. Culture positivity may correlate with long-term mortality in critically ill patients. BMC Infect Dis 2021;21:1188. [PMID: 34836508 DOI: 10.1186/s12879-021-06898-8] [Reference Citation Analysis]
7 Wen ZL, Zhang LD, Liu SZ, Liu J, Chen YZ, Chen DC. Effect of broad-spectrum antibiotics on bacterial translocation in burned or septic rats. Chin Med J (Engl) 2019;132:1179-87. [PMID: 31140989 DOI: 10.1097/CM9.0000000000000242] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
8 Timsit JF, Ruppe E, Ferrer R. Focus on sepsis: new concepts and findings in sepsis care. Intensive Care Med 2018;44:1997-9. [PMID: 30306194 DOI: 10.1007/s00134-018-5406-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
9 Tourelle KM, Boutin S, Weigand MA, Schmitt FCF. Sepsis and the Human Microbiome. Just Another Kind of Organ Failure? A Review. J Clin Med 2021;10:4831. [PMID: 34768350 DOI: 10.3390/jcm10214831] [Reference Citation Analysis]
10 Limketkai BN, Hendler S, Ting P, Parian AM. Fecal Microbiota Transplantation for the Critically Ill Patient. Nutrition in Clinical Practice 2019;34:73-9. [DOI: 10.1002/ncp.10228] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
11 Chou RH, Wu PS, Wang SC, Wu CH, Lu SF, Lien RY, Tsai YL, Lu YW, Kuo MR, Guo JY, Chou RY, Huang PH, Lin SJ. Paradox of trimethylamine-N-oxide, the impact of malnutrition on microbiota-derived metabolites and septic patients. J Intensive Care 2021;9:65. [PMID: 34674768 DOI: 10.1186/s40560-021-00581-5] [Reference Citation Analysis]
12 Battaglini D, Robba C, Fedele A, Trancǎ S, Sukkar SG, Di Pilato V, Bassetti M, Giacobbe DR, Vena A, Patroniti N, Ball L, Brunetti I, Torres Martí A, Rocco PRM, Pelosi P. The Role of Dysbiosis in Critically Ill Patients With COVID-19 and Acute Respiratory Distress Syndrome. Front Med (Lausanne) 2021;8:671714. [PMID: 34150807 DOI: 10.3389/fmed.2021.671714] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Roquilly A, Torres A, Villadangos JA, Netea MG, Dickson R, Becher B, Asehnoune K. Pathophysiological role of respiratory dysbiosis in hospital-acquired pneumonia. Lancet Respir Med 2019;7:710-20. [PMID: 31182406 DOI: 10.1016/S2213-2600(19)30140-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 7.3] [Reference Citation Analysis]
14 Wolff NS, Hugenholtz F, Wiersinga WJ. The emerging role of the microbiota in the ICU. Crit Care 2018;22:78. [PMID: 29559006 DOI: 10.1186/s13054-018-1999-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
15 Albert-Vega C, Tawfik DM, Trouillet-Assant S, Vachot L, Mallet F, Textoris J. Immune Functional Assays, From Custom to Standardized Tests for Precision Medicine. Front Immunol 2018;9:2367. [PMID: 30386334 DOI: 10.3389/fimmu.2018.02367] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 6.8] [Reference Citation Analysis]
16 Ruppé É, Lisboa T, Barbier F. The gut microbiota of critically ill patients: first steps in an unexplored world. Intensive Care Med 2018;44:1561-4. [PMID: 30008112 DOI: 10.1007/s00134-018-5309-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
17 Szychowiak P, Villageois-Tran K, Patrier J, Timsit JF, Ruppé É. The role of the microbiota in the management of intensive care patients. Ann Intensive Care 2022;12:3. [PMID: 34985651 DOI: 10.1186/s13613-021-00976-5] [Reference Citation Analysis]
18 Alagna L, Haak BW, Gori A. Fecal microbiota transplantation in the ICU: perspectives on future implementations. Intensive Care Med 2019;45:998-1001. [PMID: 31127327 DOI: 10.1007/s00134-019-05645-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
19 Schmitt FCF, Brenner T, Uhle F, Loesch S, Hackert T, Ulrich A, Hofer S, Dalpke AH, Weigand MA, Boutin S. Gut microbiome patterns correlate with higher postoperative complication rates after pancreatic surgery. BMC Microbiol. 2019;19:42. [PMID: 30777006 DOI: 10.1186/s12866-019-1399-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
20 Di Pierro F. Gut Microbiota Parameters Potentially Useful in Clinical Perspective. Microorganisms 2021;9:2402. [PMID: 34835527 DOI: 10.3390/microorganisms9112402] [Reference Citation Analysis]
21 Yao B, Liu JY, Cai SX, Zhao WJ, Xing JY. Alteration of gut microbiota and metabolomics in critically ill patients by sequential feeding: A pilot study. JPEN J Parenter Enteral Nutr 2021. [PMID: 34042183 DOI: 10.1002/jpen.2198] [Reference Citation Analysis]
22 van der Poll T, Shankar-Hari M, Wiersinga WJ. The immunology of sepsis. Immunity 2021;54:2450-64. [PMID: 34758337 DOI: 10.1016/j.immuni.2021.10.012] [Reference Citation Analysis]
23 Fontaine C, Armand-Lefèvre L, Magnan M, Nazimoudine A, Timsit JF, Ruppé E. Relationship between the composition of the intestinal microbiota and the tracheal and intestinal colonization by opportunistic pathogens in intensive care patients. PLoS One 2020;15:e0237260. [PMID: 32857755 DOI: 10.1371/journal.pone.0237260] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Virk HS, Wiersinga WJ. Current place of probiotics for VAP. Crit Care 2019;23:46. [PMID: 30760310 DOI: 10.1186/s13054-019-2325-9] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Gamage HKAH, Venturini C, Tetu SG, Kabir M, Nayyar V, Ginn AN, Roychoudhry B, Thomas L, Brown M, Holmes A, Partridge SR, Seppelt I, Paulsen IT, Iredell JR. Third generation cephalosporins and piperacillin/tazobactam have distinct impacts on the microbiota of critically ill patients. Sci Rep 2021;11:7252. [PMID: 33790304 DOI: 10.1038/s41598-021-85946-4] [Reference Citation Analysis]
26 Mikaelyan KA, Krylov KY, Petrova MV, Shestopalov AE. [Intestine morphology and microbiocenosis changes in critically ill patients in neurosurgery]. Zh Vopr Neirokhir Im N N Burdenko 2021;85:104-10. [PMID: 33560626 DOI: 10.17116/neiro202185011104] [Reference Citation Analysis]
27 Yu C, Zhu X, Zheng C, Luo Y, Wang F, Gao Y, Wu H, Sun X, Kong X. Methyl Diet Enhanced Sepsis-Induced Mortality Through Altering Gut Microbiota. J Inflamm Res 2021;14:3107-21. [PMID: 34276224 DOI: 10.2147/JIR.S305202] [Reference Citation Analysis]
28 Qi X, Qu H, Yang D, Zhou L, He YW, Yu Y, Qu J, Liu J. Lower respiratory tract microbial composition was diversified in Pseudomonas aeruginosa ventilator-associated pneumonia patients. Respir Res 2018;19:139. [PMID: 30049266 DOI: 10.1186/s12931-018-0847-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
29 Chen G, Huang B, Fu S, Li B, Ran X, He D, Jiang L, Li Y, Liu B, Xie L, Liu J, Wang W. G Protein-Coupled Receptor 109A and Host Microbiota Modulate Intestinal Epithelial Integrity During Sepsis. Front Immunol 2018;9:2079. [PMID: 30271409 DOI: 10.3389/fimmu.2018.02079] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
30 Aardema H, Lisotto P, Kurilshikov A, Diepeveen JRJ, Friedrich AW, Sinha B, de Smet AMGA, Harmsen HJM. Marked Changes in Gut Microbiota in Cardio-Surgical Intensive Care Patients: A Longitudinal Cohort Study. Front Cell Infect Microbiol 2019;9:467. [PMID: 32010644 DOI: 10.3389/fcimb.2019.00467] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
31 Cutuli SL, Carelli S, De Pascale G. The gut in critically ill patients: how unrecognized "7th organ dysfunction" feeds sepsis. Minerva Anestesiol 2020;86:595-7. [PMID: 32605359 DOI: 10.23736/S0375-9393.20.14504-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
32 Lamarche D, Johnstone J, Zytaruk N, Clarke F, Hand L, Loukov D, Szamosi JC, Rossi L, Schenck LP, Verschoor CP, McDonald E, Meade MO, Marshall JC, Bowdish DME, Karachi T, Heels-Ansdell D, Cook DJ, Surette MG; PROSPECT Investigators., Canadian Critical Care Trials Group., Canadian Critical Care Translational Biology Group. Microbial dysbiosis and mortality during mechanical ventilation: a prospective observational study. Respir Res 2018;19:245. [PMID: 30526610 DOI: 10.1186/s12931-018-0950-5] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 8.3] [Reference Citation Analysis]
33 Wijeyesekera A, Wagner J, De Goffau M, Thurston S, Rodrigues Sabino A, Zaher S, White D, Ridout J, Peters MJ, Ramnarayan P, Branco RG, Torok ME, Valla F, Meyer R, Klein N, Frost G, Parkhill J, Holmes E, Pathan N. Multi-Compartment Profiling of Bacterial and Host Metabolites Identifies Intestinal Dysbiosis and Its Functional Consequences in the Critically Ill Child. Crit Care Med 2019;47:e727-34. [PMID: 31169619 DOI: 10.1097/CCM.0000000000003841] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
34 Venturini C, Ginn AN, Wilson BE, Tsafnat G, Paulsen I, Partridge SR, Iredell JR. Ecological effects of cefepime use during antibiotic cycling on the Gram-negative enteric flora of ICU patients. Intensive Care Med Exp 2018;6:19. [PMID: 30054764 DOI: 10.1186/s40635-018-0185-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
35 Libert C, Ayala A, Bauer M, Cavaillon JM, Deutschman C, Frostell C, Knapp S, Kozlov AV, Wang P, Osuchowski MF, Remick DG. Part II: Minimum Quality Threshold in Preclinical Sepsis Studies (MQTiPSS) for Types of Infections and Organ Dysfunction Endpoints. Shock 2019;51:23-32. [PMID: 30106873 DOI: 10.1097/SHK.0000000000001242] [Cited by in Crossref: 31] [Cited by in F6Publishing: 14] [Article Influence: 15.5] [Reference Citation Analysis]
36 Guo Y, Xu M, Shi G, Zhang J. A new strategy of enteral nutrition intervention for ICU patients targeting intestinal flora. Medicine (Baltimore) 2021;100:e27763. [PMID: 34964735 DOI: 10.1097/MD.0000000000027763] [Reference Citation Analysis]
37 Bhalodi AA, van Engelen TSR, Virk HS, Wiersinga WJ. Impact of antimicrobial therapy on the gut microbiome. J Antimicrob Chemother 2019;74:i6-i15. [PMID: 30690540 DOI: 10.1093/jac/dky530] [Cited by in Crossref: 73] [Cited by in F6Publishing: 66] [Article Influence: 36.5] [Reference Citation Analysis]
38 Kullberg RFJ, Wiersinga WJ, Haak BW. Gut microbiota and sepsis: from pathogenesis to novel treatments. Curr Opin Gastroenterol 2021;37:578-85. [PMID: 34419965 DOI: 10.1097/MOG.0000000000000781] [Reference Citation Analysis]
39 Grasselli G, Scaravilli V, Alagna L, Bombino M, De Falco S, Bandera A, Abbruzzese C, Patroniti N, Gori A, Pesenti A. Gastrointestinal colonization with multidrug-resistant Gram-negative bacteria during extracorporeal membrane oxygenation: effect on the risk of subsequent infections and impact on patient outcome. Ann Intensive Care 2019;9:141. [PMID: 31853672 DOI: 10.1186/s13613-019-0615-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
40 Wolff NS, Jacobs MC, Wiersinga WJ, Hugenholtz F. Pulmonary and intestinal microbiota dynamics during Gram-negative pneumonia-derived sepsis. Intensive Care Med Exp 2021;9:35. [PMID: 34250564 DOI: 10.1186/s40635-021-00398-4] [Reference Citation Analysis]
41 Yin L, Wan YD, Pan XT, Zhou CY, Lin N, Ma CT, Yao J, Su Z, Wan C, Yu YW, Zhu RX. Association Between Gut Bacterial Diversity and Mortality in Septic Shock Patients: A Cohort Study. Med Sci Monit 2019;25:7376-82. [PMID: 31574078 DOI: 10.12659/MSM.916808] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Mesa MD, Loureiro B, Iglesia I, Fernandez Gonzalez S, Llurba Olivé E, García Algar O, Solana MJ, Cabero Perez MJ, Sainz T, Martinez L, Escuder-Vieco D, Parra-Llorca A, Sánchez-Campillo M, Rodriguez Martinez G, Gómez Roig D, Perez Gruz M, Andreu-Fernández V, Clotet J, Sailer S, Iglesias-Platas I, López-Herce J, Aras R, Pallás-Alonso C, de Pipaon MS, Vento M, Gormaz M, Larqué Daza E, Calvo C, Cabañas F. The Evolving Microbiome from Pregnancy to Early Infancy: A Comprehensive Review. Nutrients 2020;12:E133. [PMID: 31906588 DOI: 10.3390/nu12010133] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 12.0] [Reference Citation Analysis]
43 Liu W, Cheng M, Li J, Zhang P, Fan H, Hu Q, Han M, Su L, He H, Tong Y, Ning K, Long Y. Classification of the Gut Microbiota of Patients in Intensive Care Units During Development of Sepsis and Septic Shock. Genomics Proteomics Bioinformatics 2020;18:696-707. [PMID: 33607294 DOI: 10.1016/j.gpb.2020.06.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Qiang W, Xuan H, Yu S, Hailun P, Yueli Z, Zhiguo P, Lei S. Impact of the gut microbiota on heat stroke rat mediated by Xuebijing metabolism. Microb Pathog 2021;155:104861. [PMID: 33864878 DOI: 10.1016/j.micpath.2021.104861] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Xu R, Tan C, Zhu J, Zeng X, Gao X, Wu Q, Chen Q, Wang H, Zhou H, He Y, Pan S, Yin J. Dysbiosis of the intestinal microbiota in neurocritically ill patients and the risk for death. Crit Care 2019;23:195. [PMID: 31151471 DOI: 10.1186/s13054-019-2488-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
46 Otani S, Chihade DB, Coopersmith CM. Critical illness and the role of the microbiome. Acute Med Surg 2019;6:91-4. [PMID: 30976432 DOI: 10.1002/ams2.383] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
47 Wan YD, Zhu RX, Wu ZQ, Lyu SY, Zhao LX, Du ZJ, Pan XT. Gut Microbiota Disruption in Septic Shock Patients: A Pilot Study. Med Sci Monit 2018;24:8639-46. [PMID: 30488879 DOI: 10.12659/MSM.911768] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
48 Souffriau J, Timmermans S, Vanderhaeghen T, Wallaeys C, Van Looveren K, Aelbrecht L, Dewaele S, Vandewalle J, Goossens E, Verbanck S, Boyen F, Eggermont M, De Commer L, De Rycke R, De Bruyne M, Tito R, Ballegeer M, Vandevyver S, Velho T, Moita LF, Hochepied T, De Bosscher K, Raes J, Van Immerseel F, Beyaert R, Libert C. Zinc inhibits lethal inflammatory shock by preventing microbe-induced interferon signature in intestinal epithelium. EMBO Mol Med 2020;12:e11917. [PMID: 32914580 DOI: 10.15252/emmm.201911917] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Schuurman AR, Reijnders TDY, Kullberg RFJ, Butler JM, van der Poll T, Wiersinga WJ. Sepsis: deriving biological meaning and clinical applications from high-dimensional data. Intensive Care Med Exp 2021;9:27. [PMID: 33961170 DOI: 10.1186/s40635-021-00383-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 Rubio I, Osuchowski MF, Shankar-hari M, Skirecki T, Winkler MS, Lachmann G, La Rosée P, Monneret G, Venet F, Bauer M, Brunkhorst FM, Kox M, Cavaillon J, Uhle F, Weigand MA, Flohé SB, Wiersinga WJ, Martin-fernandez M, Almansa R, Martin-loeches I, Torres A, Giamarellos-bourboulis EJ, Girardis M, Cossarizza A, Netea MG, van der Poll T, Scherag A, Meisel C, Schefold JC, Bermejo-martín JF. Current gaps in sepsis immunology: new opportunities for translational research. The Lancet Infectious Diseases 2019;19:e422-36. [DOI: 10.1016/s1473-3099(19)30567-5] [Cited by in Crossref: 59] [Cited by in F6Publishing: 38] [Article Influence: 19.7] [Reference Citation Analysis]
51 Li YT, Huang JR, Peng ML. Current Status and Prospects of Spontaneous Peritonitis in Patients with Cirrhosis. Biomed Res Int 2020;2020:3743962. [PMID: 32724800 DOI: 10.1155/2020/3743962] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
52 Barash M, Patel JJ. Gut Luminal and Clinical Benefits of Early Enteral Nutrition in Shock. Curr Surg Rep 2019;7. [DOI: 10.1007/s40137-019-0243-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
53 Blesl A, Jüngst C, Lammert F, Fauler G, Rainer F, Leber B, Feldbacher N, Stromberger S, Wildburger R, Spindelböck W, Fickert P, Horvath A, Stadlbauer V. Secondary Sclerosing Cholangitis in Critically Ill Patients Alters the Gut-Liver Axis: A Case Control Study. Nutrients 2020;12:E2728. [PMID: 32906634 DOI: 10.3390/nu12092728] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
54 Bansal S, Nguyen JP, Leligdowicz A, Zhang Y, Kain KC, Ricciuto DR, Coburn B. Rectal and Naris Swabs: Practical and Informative Samples for Analyzing the Microbiota of Critically Ill Patients. mSphere 2018;3:e00219-18. [PMID: 29898981 DOI: 10.1128/mSphere.00219-18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
55 Salomon J, Ericsson A, Price A, Manithody C, Murry DJ, Chhonker YS, Buchanan P, Lindsey ML, Singh AB, Jain AK. Dysbiosis and Intestinal Barrier Dysfunction in Pediatric Congenital Heart Disease Is Exacerbated Following Cardiopulmonary Bypass. JACC Basic Transl Sci 2021;6:311-27. [PMID: 33997519 DOI: 10.1016/j.jacbts.2020.12.012] [Reference Citation Analysis]
56 Van Vooren S, De Waele JJ, Boelens J, Polet M, Stove V, Vanhaecke L, Verstraete AG. Development and validation of a liquid chromatography high-resolution mass spectrometry orbitrap method for the sensitive quantification of amoxicillin, piperacillin, tazobactam and meropenem in human faeces. Anal Chim Acta 2021;1177:338760. [PMID: 34482897 DOI: 10.1016/j.aca.2021.338760] [Reference Citation Analysis]
57 Wiersinga WJ. The gut microbiome takes center stage in critical care. Curr Opin Crit Care 2017;23:140-2. [PMID: 28107225 DOI: 10.1097/MCC.0000000000000390] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
58 Moron R, Galvez J, Colmenero M, Anderson P, Cabeza J, Rodriguez-Cabezas ME. The Importance of the Microbiome in Critically Ill Patients: Role of Nutrition. Nutrients 2019;11:E3002. [PMID: 31817895 DOI: 10.3390/nu11123002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
59 Jacobs MC, Haak BW, Hugenholtz F, Wiersinga WJ. Gut microbiota and host defense in critical illness. Curr Opin Crit Care 2017;23:257-63. [PMID: 28548992 DOI: 10.1097/MCC.0000000000000424] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 5.8] [Reference Citation Analysis]
60 Harris VC, Haak BW, Boele van Hensbroek M, Wiersinga WJ. The Intestinal Microbiome in Infectious Diseases: The Clinical Relevance of a Rapidly Emerging Field. Open Forum Infect Dis 2017;4:ofx144. [PMID: 28852682 DOI: 10.1093/ofid/ofx144] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
61 Yang XJ, Liu D, Ren HY, Zhang XY, Zhang J, Yang XJ. Effects of sepsis and its treatment measures on intestinal flora structure in critical care patients. World J Gastroenterol 2021; 27(19): 2376-2393 [PMID: 34040329 DOI: 10.3748/wjg.v27.i19.2376] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Schmitt FCF, Schneider M, Mathejczyk W, Weigand MA, Figueiredo JC, Li CI, Shibata D, Siegel EM, Toriola AT, Ulrich CM, Ulrich AB, Boutin S, Gigic B. Postoperative Complications Are Associated with Long-Term Changes in the Gut Microbiota Following Colorectal Cancer Surgery. Life (Basel) 2021;11:246. [PMID: 33809741 DOI: 10.3390/life11030246] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
63 Livanos AE, Snider EJ, Whittier S, Chong DH, Wang TC, Abrams JA, Freedberg DE. Rapid gastrointestinal loss of Clostridial Clusters IV and XIVa in the ICU associates with an expansion of gut pathogens. PLoS One 2018;13:e0200322. [PMID: 30067768 DOI: 10.1371/journal.pone.0200322] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
64 D Goldenberg S, Merrick B. The role of faecal microbiota transplantation: looking beyond Clostridioides difficile infection. Ther Adv Infect Dis 2021;8:2049936120981526. [PMID: 33614028 DOI: 10.1177/2049936120981526] [Reference Citation Analysis]
65 Zhang D, Li H, Li Y, Qu L. Gut rest strategy and trophic feeding in the acute phase of critical illness with acute gastrointestinal injury. Nutr Res Rev 2019;32:176-82. [PMID: 30919797 DOI: 10.1017/S0954422419000027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
66 Wang C, Li Q, Ren J. Microbiota-Immune Interaction in the Pathogenesis of Gut-Derived Infection. Front Immunol. 2019;10:1873. [PMID: 31456801 DOI: 10.3389/fimmu.2019.01873] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
67 Beyaert R, Libert C. How Good Roommates Can Protect against Microbial Sepsis. Cell Host Microbe 2018;23:283-5. [PMID: 29544090 DOI: 10.1016/j.chom.2018.02.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
68 Ravi A, Halstead FD, Bamford A, Casey A, Thomson NM, van Schaik W, Snelson C, Goulden R, Foster-Nyarko E, Savva GM, Whitehouse T, Pallen MJ, Oppenheim BA. Loss of microbial diversity and pathogen domination of the gut microbiota in critically ill patients. Microb Genom 2019;5. [PMID: 31526447 DOI: 10.1099/mgen.0.000293] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 5.7] [Reference Citation Analysis]
69 Thibeault C, Suttorp N, Opitz B. The microbiota in pneumonia: From protection to predisposition. Sci Transl Med 2021;13:eaba0501. [PMID: 33441423 DOI: 10.1126/scitranslmed.aba0501] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
70 Cao H, Zong C, Dai W, Gao Q, Li D, Wu X, Li D, Tang YW, Wu S. The Effects of Chinese Medicine QRD, Antibiotics, and Probiotics on Therapy and Gut Microbiota in Septic Rats. Front Cell Infect Microbiol 2021;11:712028. [PMID: 34722329 DOI: 10.3389/fcimb.2021.712028] [Reference Citation Analysis]
71 Tourelle KM, Boutin S, Weigand MA, Schmitt FCF. The Association of Gut Microbiota and Complications in Gastrointestinal-Cancer Therapies. Biomedicines 2021;9:1305. [PMID: 34680424 DOI: 10.3390/biomedicines9101305] [Reference Citation Analysis]
72 Habes QL, Konstanti P, Kiers HD, Koch RM, Stolk RF, Belzer C, Kox M, Pickkers P. No interplay between gut microbiota composition and the lipopolysaccharide-induced innate immune response in humans in vivo. Clin Transl Immunology 2021;10:e1278. [PMID: 33968408 DOI: 10.1002/cti2.1278] [Reference Citation Analysis]
73 Fay KT, Klingensmith NJ, Chen CW, Zhang W, Sun Y, Morrow KN, Liang Z, Burd EM, Ford ML, Coopersmith CM. The gut microbiome alters immunophenotype and survival from sepsis. FASEB J 2019;33:11258-69. [PMID: 31306584 DOI: 10.1096/fj.201802188R] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
74 Oami T, Chihade DB, Coopersmith CM. The microbiome and nutrition in critical illness. Curr Opin Crit Care 2019;25:145-9. [PMID: 30855323 DOI: 10.1097/MCC.0000000000000582] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
75 Vossen E, Goethals S, De Vrieze J, Boon N, Van Hecke T, De Smet S. Red and processed meat consumption within two different dietary patterns: Effect on the colon microbial community and volatile metabolites in pigs. Food Res Int 2020;129:108793. [PMID: 32036914 DOI: 10.1016/j.foodres.2019.108793] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
76 Kim MH, Choi JH. An Update on Sepsis Biomarkers. Infect Chemother 2020;52:1-18. [PMID: 32239808 DOI: 10.3947/ic.2020.52.1.1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
77 Nakov R, Segal JP, Settanni CR, Bibbò S, Gasbarrini A, Cammarota G, Ianiro G. Microbiome: what intensivists should know. Minerva Anestesiol 2020;86:777-85. [PMID: 32368882 DOI: 10.23736/S0375-9393.20.14278-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
78 Ojima M, Shimizu K, Motooka D, Ishihara T, Nakamura S, Shintani A, Ogura H, Iida T, Yoshiya K, Shimazu T. Gut Dysbiosis Associated with Antibiotics and Disease Severity and Its Relation to Mortality in Critically Ill Patients. Dig Dis Sci 2021. [PMID: 33939152 DOI: 10.1007/s10620-021-07000-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Adelman MW, Woodworth MH, Langelier C, Busch LM, Kempker JA, Kraft CS, Martin GS. The gut microbiome's role in the development, maintenance, and outcomes of sepsis. Crit Care 2020;24:278. [PMID: 32487252 DOI: 10.1186/s13054-020-02989-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
80 Berzero G, Psimaras D, Weiss N, Sokol H, Alentorn A. Gut microbiome alterations in anti-NMDA receptor encephalitis: caveats for result interpretation. Ann Clin Transl Neurol 2020;7:153-4. [PMID: 31880105 DOI: 10.1002/acn3.50970] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
81 Du B, Shen N, Tao Y, Sun S, Zhang F, Ren H, Cao Q, Mo X. Analysis of gut microbiota alteration and application as an auxiliary prognostic marker for sepsis in children: a pilot study. Transl Pediatr 2021;10:1647-57. [PMID: 34295779 DOI: 10.21037/tp-21-51] [Reference Citation Analysis]
82 Haak BW, Levi M, Wiersinga WJ. Microbiota-targeted therapies on the intensive care unit. Curr Opin Crit Care. 2017;23:167-174. [PMID: 28092309 DOI: 10.1097/mcc.0000000000000389] [Cited by in Crossref: 30] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
83 Iapichino G, Lankelma JM, Joost Wiersinga W. Gut microbiota disruption in critically ill patients : Discussion on "Critically ill patients demonstrate large interpersonal variation of intestinal microbiota dysregulation: a pilot study". Intensive Care Med 2017;43:718-9. [PMID: 28233052 DOI: 10.1007/s00134-017-4713-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
84 Toni T, Alverdy J, Gershuni V. Re-examining chemically defined liquid diets through the lens of the microbiome. Nat Rev Gastroenterol Hepatol 2021;18:903-11. [PMID: 34594028 DOI: 10.1038/s41575-021-00519-0] [Reference Citation Analysis]
85 Yuan JJ, Chang XN, Li M, Yuan QX, Yang XL. Clinical utility of characterizing intestinal flora in septic kidney injury. Chin Med J (Engl) 2020;133:842-6. [PMID: 32149763 DOI: 10.1097/CM9.0000000000000724] [Reference Citation Analysis]
86 Jung CY, Bae JM. Pathophysiology and protective approaches of gut injury in critical illness. Yeungnam Univ J Med 2021;38:27-33. [PMID: 33022904 DOI: 10.12701/yujm.2020.00703] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
87 Toribio-Mateas M. Harnessing the Power of Microbiome Assessment Tools as Part of Neuroprotective Nutrition and Lifestyle Medicine Interventions. Microorganisms 2018;6:E35. [PMID: 29693607 DOI: 10.3390/microorganisms6020035] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
88 Haak BW, Prescott HC, Wiersinga WJ. Therapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis. Front Immunol. 2018;9:2042. [PMID: 30250472 DOI: 10.3389/fimmu.2018.02042] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 11.5] [Reference Citation Analysis]
89 Wernerman J, Christopher KB, Annane D, Casaer MP, Coopersmith CM, Deane AM, De Waele E, Elke G, Ichai C, Karvellas CJ, McClave SA, Oudemans-van Straaten HM, Rooyackers O, Stapleton RD, Takala J, van Zanten ARH, Wischmeyer PE, Preiser JC, Vincent JL. Metabolic support in the critically ill: a consensus of 19. Crit Care 2019;23:318. [PMID: 31533772 DOI: 10.1186/s13054-019-2597-0] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 10.7] [Reference Citation Analysis]
90 Dionne JC, Sullivan K, Mbuagbaw L, Takaoka A, Duan EH, Alhazzani W, Devlin JW, Duprey M, Moayyedi P, Armstrong D, Thabane L, Tsang JLY, Jaeschke R, Hamielec C, Karachi T, Cartin-Ceba R, Muscedere J, Alshahrani MSS, Cook DJ. Diarrhoea: interventions, consequences and epidemiology in the intensive care unit (DICE-ICU): a protocol for a prospective multicentre cohort study. BMJ Open 2019;9:e028237. [PMID: 31248929 DOI: 10.1136/bmjopen-2018-028237] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
91 Otani S, Coopersmith CM. Gut integrity in critical illness. J Intensive Care 2019;7:17. [PMID: 30923621 DOI: 10.1186/s40560-019-0372-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
92 Haak BW, Argelaguet R, Kinsella CM, Kullberg RFJ, Lankelma JM, Deijs M, Klein M, Jebbink MF, Hugenholtz F, Kostidis S, Giera M, Hakvoort TBM, de Jonge WJ, Schultz MJ, van Gool T, van der Poll T, de Vos WM, van der Hoek LM, Wiersinga WJ. Integrative Transkingdom Analysis of the Gut Microbiome in Antibiotic Perturbation and Critical Illness. mSystems 2021;6:e01148-20. [PMID: 33727397 DOI: 10.1128/mSystems.01148-20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
93 Schmitt FCF, Lipinski A, Hofer S, Uhle F, Nusshag C, Hackert T, Dalpke AH, Weigand MA, Brenner T, Boutin S. Pulmonary microbiome patterns correlate with the course of the disease in patients with sepsis-induced ARDS following major abdominal surgery. J Hosp Infect 2020:S0195-6701(20)30203-6. [PMID: 32339614 DOI: 10.1016/j.jhin.2020.04.028] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
94 Ruppé E, Martin-Loeches I, Rouzé A, Levast B, Ferry T, Timsit JF. What's new in restoring the gut microbiota in ICU patients? Potential role of faecal microbiota transplantation. Clin Microbiol Infect 2018;24:803-5. [PMID: 29870851 DOI: 10.1016/j.cmi.2018.05.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
95 Miniet AA, Grunwell JR, Coopersmith CM. The microbiome and the immune system in critical illness. Curr Opin Crit Care 2021;27:157-63. [PMID: 33405413 DOI: 10.1097/MCC.0000000000000800] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
96 Karunaratne TB, Okereke C, Seamon M, Purohit S, Wakade C, Sharma A. Niacin and Butyrate: Nutraceuticals Targeting Dysbiosis and Intestinal Permeability in Parkinson's Disease. Nutrients 2020;13:E28. [PMID: 33374784 DOI: 10.3390/nu13010028] [Cited by in F6Publishing: 1] [Reference Citation Analysis]